Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The weeks and months after a baby is born are a critical time for the growth of the heart of premature babies. This is largely because they are faced with major blood flow changes and increased oxygen demands as they transition to the outside environment during a time where they would normally be developing inside their mother.

A lot of research has identified preterm birth (born before 37 weeks gestation) as a risk factor for developing early heart disease, including heart failure. Heart failure is when the heart can’t pump blood around your body as effectively as it should.

Several studies have shown that preterm birth is linked to abnormalities in the structure and function of their heart, yet the extent and evolution of these changes throughout development, from birth to adulthood, are not well defined. However, it’s important that they are defined as one in ten people worldwide are born preterm.

In our latest study, we performed a meta-analysis of data from published studies that compared the heart’s structure and function using echocardiography or cardiovascular magnetic resonance imaging for people born preterm versus those born at term.

Read the full article on The Conversation website, written by Dr Adam Lewandowski, Radcliffe Department of Medicine.

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Earliest origins of the forming heart identified

CRE Research

The earliest known progenitor of the outermost layer of the heart has been characterised for the first time and linked to the development of other critical cell types in the developing heart in a new paper from the Srinivas group led by BHF Immediate Fellow Dr Richard Tyser.

Professor Sir Rory Collins awarded the MRC Millennium Medal 2020

CRE Research

Professor Sir Rory Collins, Head of the Nuffield Department of Population Health, and Principal Investigator and Chief Executive of UK Biobank, has been awarded the Medical Research Council (MRC) Millennium Medal 2020, the MRC’s most prestigious personal award.

New MRI technique could detect early signs of heart failure in cancer patients following chemotherapy

CRE Publication Research

New research led by Oxford BHF CRE Intermediate Transition Fellow Dr Kerstin Timm shows that a recently developed imaging technique pioneered by the Tyler Group can detect early metabolic changes in the heart caused by a commonly used chemotherapy drug, which is known to increase risk of heart failure in cancer survivors.

Two major BHF awards to Neil Herring pave the way to new treatments for heart attack patients

CRE Research

Associate Professor Neil Herring has been awarded a Senior Clinical Research Fellowship and a Project grant from the British Heart Foundation to further critical research into the mechanisms behind heart attacks and heart failure and potential drugs to combat them. Given the 50% reduction in research investment this year from the BHF due to the impact of COVID-19, Prof Herring is to be congratulated on these awards.